(Q41628622)

5 October 2017

1 reference

title

Inhaled nitric oxide in the neonate with cardiac disease (English)

1 reference

5 October 2017

Atz AM

1

1 reference

PubMed ID

9352616

5 October 2017

Wessel DL

series ordinal

2

1 reference

5 October 2017

1 October 1997

1 reference

5 October 2017

Seminars in Perinatology

1 reference

5 October 2017

21

1 reference

5 October 2017

5

1 reference

5 October 2017

441-455

1 reference

Evaluation of pediatric intensive care

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Pulmonary hypertensive crises following surgery for congenital heart defects in young children.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Pulmonary vascular disease with congenital heart lesions: pathologic features and causes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodelling studied in lung biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Primary surgical closure of ventricular septal defect in the first year of life: results in 128 infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Diagnosis and management of postoperative pulmonary hypertensive crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Management of the neonate with transposition of the great arteries and persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide reduces human lung allograft dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Extracorporeal membrane oxygenation for cardiac failure after congenital heart operation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Total anomalous pulmonary venous return. Prenatal damage to pulmonary vascular bed and extrapulmonary veins

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Rebound pulmonary hypertension after inhalation of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Pulmonary vascular disease in total anomalous pulmonary venous drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Structural study of pulmonary circulation and of heart in total anomalous pulmonary venous return in early infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Significance of the pulmonary vascular bed in congenital heart disease. V. Lesions of the left side of the heart causing obstruction of the pulmonary venous return

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide for the postoperative management of Fontan-type operations

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Clinical applications of gaseous nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Nitric oxide and prostacyclin lower suprasystemic pulmonary hypertension after cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Dipyridamole augmentation of response to nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Effective control of refractory pulmonary hypertension after cardiac operations

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Negative feedback regulation of endothelial cell function by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Nitric oxide during hand ventilation in patient with acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide can cause severe systemic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Pulmonary vasodilatory effects of 12 and 60 parts per million inhaled nitric oxide in children with ventricular septal defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Inhaled nitric oxide in congenital heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

Methaemoglobin during nitric oxide therapy with high-frequency ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

A delivery system for inhalation of nitric oxide evaluated with chemiluminescence, electrochemical fuel cells, and capnography

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980009-2

7 January 2021

10.1016/S0146-0005(97)80009-2

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9352616